Skip to main content
hello world

Closing Bell: Eupraxia Pharmaceuticals Inc down on Friday (EPRX)

Automated Summaries - The Globe and Mail - Mon Aug 5, 4:01PM CDT

In market activity today, Eupraxia Pharmaceuticals Inc shares closed at $3.58 after opening the day at $3.90. prices ranged from $3.53 to $3.90.

The price decreased -6.53% from the previous day's close of $3.83.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 15,620 on 48 total trades, with an average volume of 18,154 over 5 days.

The TSX overall saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $8.46 (August 15,2023) and low as $3.25 (July 05,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have plummeted -52.27%, while they have reduced -33.33% since the start of 2024.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $127.53 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.20.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..